Diplomat, OptumRx Combining To Advance Access To Specialty Pharmacy Care & Infusion Services

OptumRx, the pharmacy care services business of Optum, and Diplomat, a provider organization for specialty pharmacy and infusion services, are combining. The agreement calls for the acquisition of Diplomat’s outstanding common stock for $4.00 per share through a cash tender offer and assumption of outstanding debt.

Diplomat brings expertise in managing specialty medications that treat individuals with complex diseases, such as oncology and immunology, and provides specialized infusion therapies offered in convenient and clinically appropriate settings in all 50 states and Washington, D.C. The combination will support improved health outcomes and reduced prescription drug costs while helping . . .